Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
48
# OF OVERLAPPING
HOLDINGS
SBIO
94
HOLDINGS
56%
ALSO IN BBC
BBC
125
HOLDINGS
46%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus BBC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in BBC |
Overlap | |
|---|---|---|---|---|
 |
AKERO THERAPEUTICS, INC. | 2.5% | 1.5% | 1.5% |
 |
MERUS N.V. | 3.0% | 1.1% | 1.1% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.0% | 1.0% | 1.0% |
|
CG ONCOLOGY, INC. | 1.2% | 0.9% | 0.9% |
|
AVIDITY BIOSCIENCES INC | 3.5% | 0.9% | 0.9% |
SBIO Overweight Relative to BBC
|
RHYTHM PHARMACEUTICALS, INC. | 3.6% |
|
AXSOME THERAPEUTICS, INC. | 3.2% |
 |
ALKERMES PLC | 2.7% |
|
AVIDITY BIOSCIENCES INC | 2.6% |
|
ACADIA PHARMACEUTICALS INC | 2.6% |
|
KRYSTAL BIOTECH, INC. | 2.5% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.4% |
|
PTC THERAPEUTICS INC | 2.2% |
|
NUVALENT, INC. CLASS A | 2.2% |
|
VIKING THERAPEUTICS, INC. | 2.0% |
SBIO Underweight Relative to BBC
|
LIQUIDIA TECHNOLOGIES, INC. | -1.4% |
|
SANA BIOTECHNOLOGY, INC. | -1.3% |
|
XERIS PHARMACEUTICALS INC | -1.3% |
|
ARCUTIS BIOTHERAPEUTICS INC | -1.2% |
|
VERVE THERAPEUTICS, INC. | -1.1% |
|
ALLOGENE THERAPEUTICS, INC. | -1.1% |
|
BEAM THERAPEUTICS, INC. | -1.0% |
|
SYNDAX PHARMACEUTICALS INC | -1.0% |
|
89BIO INC | -1.0% |
|
SUMMIT THERAPEUTICS INC | -1.0% |